| Dr Jorge Alberto Vidal, MD | |
|
619 19th St S, Birmingham, AL 35249-1900 | |
| (205) 934-8978 | |
| Not Available |
| Full Name | Dr Jorge Alberto Vidal |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 23 Years |
| Location | 619 19th St S, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487664454 | NPI | - | NPPES |
| 1487664454 | Medicaid | MO | |
| P00467069 | Other | MO | RR MEDICARE FOR GROUP DG5646 |
| 39128011 | Other | MO | BCBS KANSAS CITY MO |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Alabama Hospital | Birmingham, AL | Hospital |
| University Of Missouri Health Care | Columbia, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Curators Of The University Of Missouri | 4486759560 | 959 |
| University Of Alabama Health Services Foundation, Pc | 1951213107 | 2344 |
News Archive
Women who have undergone group therapy and learned to relax have reduced their menopausal troubles by half, according to results of a study at Linköping University and Linköping University Hospital in Sweden.
Patients whose nose has been destroyed by a tumor or injury carry a severe psychological and social burden.
Cancer Research UK funded scientists have identified two common genetic variants that could triple a person's risk of getting bowel cancer. Their findings are published in Nature Genetics (Sunday).
Amgen today announced that the Phase 3 PRIME "203" trial evaluating Vectibix® (panitumumab) administered in combination with FOLFOX (an oxaliplatin-based chemotherapy) as a first-line treatment of metastatic colorectal cancer (mCRC) failed to meet a secondary endpoint of overall survival.
Researchers in Sweden and China have presented a new methodology for predicting mutation "hotspot" sites within severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.
› Verified 7 days ago
| Entity Name | The Curators Of The University Of Missouri |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235126921 PECOS PAC ID: 4486759560 Enrollment ID: O20070418000290 |
News Archive
Women who have undergone group therapy and learned to relax have reduced their menopausal troubles by half, according to results of a study at Linköping University and Linköping University Hospital in Sweden.
Patients whose nose has been destroyed by a tumor or injury carry a severe psychological and social burden.
Cancer Research UK funded scientists have identified two common genetic variants that could triple a person's risk of getting bowel cancer. Their findings are published in Nature Genetics (Sunday).
Amgen today announced that the Phase 3 PRIME "203" trial evaluating Vectibix® (panitumumab) administered in combination with FOLFOX (an oxaliplatin-based chemotherapy) as a first-line treatment of metastatic colorectal cancer (mCRC) failed to meet a secondary endpoint of overall survival.
Researchers in Sweden and China have presented a new methodology for predicting mutation "hotspot" sites within severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jorge Alberto Vidal, MD Po Box 55310, Birmingham, AL 35255-5310 Ph: () - | Dr Jorge Alberto Vidal, MD 619 19th St S, Birmingham, AL 35249-1900 Ph: (205) 934-8978 |
News Archive
Women who have undergone group therapy and learned to relax have reduced their menopausal troubles by half, according to results of a study at Linköping University and Linköping University Hospital in Sweden.
Patients whose nose has been destroyed by a tumor or injury carry a severe psychological and social burden.
Cancer Research UK funded scientists have identified two common genetic variants that could triple a person's risk of getting bowel cancer. Their findings are published in Nature Genetics (Sunday).
Amgen today announced that the Phase 3 PRIME "203" trial evaluating Vectibix® (panitumumab) administered in combination with FOLFOX (an oxaliplatin-based chemotherapy) as a first-line treatment of metastatic colorectal cancer (mCRC) failed to meet a secondary endpoint of overall survival.
Researchers in Sweden and China have presented a new methodology for predicting mutation "hotspot" sites within severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.
› Verified 7 days ago
Dr. Garrett Colby, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Jt N342, Birmingham, AL 35249 Phone: 205-934-3108 Fax: 205-975-4413 | |
Drexell H Boggs, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1700 6th Ave S, Rm: 2253, Birmingham, AL 35233 Phone: 205-975-9399 Fax: 205-975-5184 | |
James Walker, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Joseph Smith, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Michelle M Mcnamara, MD Radiology Medicare: Medicare Enrolled Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-4011 | |
Sharda Mehar Bajaj, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1526 5th Ave S, Birmingham, AL 35233 Phone: 205-279-2860 | |
Gina Elizabeth Rebesco, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 625 19th St S, Birmingham, AL 35233 Phone: 205-975-0222 |